Next report date
Report period
H2 2024
EPS estimate
—
Revenue estimate
—
−1.05 MAUD
6.02 MAUD
220.01 M
Om PHARMX TECHNOLOGIES LIMITED
Sektor
VD
Tom Culver
Webbplats
Huvudkvarter
Sydney
Grundat
1950
ISIN
AU0000298762
FIGI
BBG000BQ8554
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
